These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


487 related items for PubMed ID: 21675497

  • 1. Fabry disease.
    Tarabuso AL.
    Skinmed; 2011; 9(3):173-7. PubMed ID: 21675497
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of patients with Fabry disease in Argentina].
    AADELFA (Asociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales).
    Medicina (B Aires); 2010; 70(1):37-43. PubMed ID: 20228022
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Fabry disease].
    Jakubowska E, Ryba M, Hruby Z.
    Przegl Lek; 2006; 63(4):218-9. PubMed ID: 17080745
    [Abstract] [Full Text] [Related]

  • 5. Fabry disease: treatment and diagnosis.
    Rozenfeld PA.
    IUBMB Life; 2009 Nov; 61(11):1043-50. PubMed ID: 19859978
    [Abstract] [Full Text] [Related]

  • 6. Fabry disease: molecular genetics of the inherited nephropathy.
    Desnick RJ, Astrin KH, Bishop DF.
    Adv Nephrol Necker Hosp; 1989 Nov; 18():113-27. PubMed ID: 2564247
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A case of multiple angiomas without any angiokeratomas in a female heterozygote with Fabry disease.
    Mirceva V, Hein R, Ring J, Möhrenschlager M.
    Australas J Dermatol; 2010 Feb; 51(1):36-8. PubMed ID: 20148840
    [Abstract] [Full Text] [Related]

  • 10. [Neurological complications of Fabry-disease].
    Vastagh I, Constantin T, Kéri A, Rudas G, Fekete G, Bereczki D.
    Ideggyogy Sz; 2011 Jan 30; 64(1-2):29-35. PubMed ID: 21428036
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Fabry disease: clinic and enzymatic diagnosis of homozygous and heterozygous. New therapeutic prospects].
    Peces R, Olea T.
    Nefrologia; 2002 Jan 30; 22(6):540-6. PubMed ID: 12516287
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Correction of enzymatic and lysosomal storage defects in Fabry mice by adenovirus-mediated gene transfer.
    Ziegler RJ, Yew NS, Li C, Cherry M, Berthelette P, Romanczuk H, Ioannou YA, Zeidner KM, Desnick RJ, Cheng SH.
    Hum Gene Ther; 1999 Jul 01; 10(10):1667-82. PubMed ID: 10428212
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients.
    Navarro C, Teijeira S, Dominguez C, Fernandez JM, Rivas E, Fachal C, Barrera S, Rodriguez C, Iranzo P.
    Acta Neuropathol; 2006 Feb 01; 111(2):178-85. PubMed ID: 16463201
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.